Evidence map›Paper›PMID 35124885›Full record

Trial reportAndrology2022

Prospective two-arm study of the testicular function in patients with COVID-19.

Dmitry Enikeev, Mark Taratkin, Andrey Morozov, Vladislav Petov, Dmitry Korolev, Anastasia Shpikina, Leonid Spivak, Svetlana Kharlamova, Irina Shchedrina, Oleg Mestnikov and 9 more

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in Andrology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 4 pooled it
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 4 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Semen parameters and sex hormones as affected by SARS-CoV-2 infection: A systematic review.Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie · 2022
    Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. SARS-CoV-2, fertility and assisted reproduction.Human reproduction update · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 3 countries.

Dmitry EnikeevInstitute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Mark TaratkinInstitute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Andrey MorozovInstitute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Vladislav PetovInstitute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Dmitry KorolevInstitute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Anastasia ShpikinaInstitute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Leonid SpivakInstitute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Svetlana KharlamovaSechenov University, Moscow, Russia.
Irina ShchedrinaSechenov University, Moscow, Russia.
Oleg MestnikovSechenov University, Moscow, Russia.
Dmitry FievInstitute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Timur GanzhaInstitute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Marina GeladzeSechenov University, Moscow, Russia.
Aichurok MambetovaSechenov University, Moscow, Russia.
Evgenia KoganDepartment of Pathology, Sechenov University, Moscow, Russia.
Nikolay ZharkovDepartment of Pathology, Sechenov University, Moscow, Russia.
Gregory DemyashkinDepartment of Pathology, Sechenov University, Moscow, Russia.
Shahrokh F ShariatInstitute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Petr GlybochkoInstitute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Sechenov University · RUThe University of Texas Southwestern Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic has led the international community to conduct extensive research into potential negative effects of the disease on multiple organs and systems in the human body. One of the most discussed areas is potential of the virus to compromise the testicular function. However, the lack of prospective studies on this topic makes it impossible to draw reliable conclusions on whether the disease affects the male reproductive system and, if so, to what extent.

objectivesThe current trial is aimed at investigating the effect of SARS-CoV-2 on the testicular function, hormone levels and determining the extent of impact on spermatogenesis and damage to testicular tissue. MATERIALS AND

methodsThis prospective study included healthy controls and cases of patients suffering from viral pneumonia based on chest computed tomography (CT) and a positive SARS-CoV-2 throat swab exhibited moderate symptoms (World Health Organization (WHO) classification). Epidemiological, clinical, laboratory and ultrasound data were collected. A semen analysis was performed in cases during their hospital stay and 3 months after the discharge home. We also assessed the testicles obtained during autopsies of patients who died of COVID-19 (n = 20).

resultsA total of 88 participants were included (44 controls and 44 cases). Blood testosterone levels were significantly decreased in 27.3% of the cases (12/44). The mean level (7.3±2.7 nmol/L) was lower than that in the healthy controls (13.5±5.2 nmol/L, p < 0.001). An increase in luteinizing hormone (LH) and follicle-stimulating hormone (FSH) was also detected compared to the healthy controls (p = 0.04 and p = 0.002). The semen analysis revealed decreased motility in COVID-19 patients (p = 0.001), and a higher number of immobile sperm (during COVID-19: 58.8% and at 3 months 47.4%, p = 0.005). All parameters returned to normal at 3 months after discharge. Direct mixed agglutination reaction (MAR) test at 3 months showed an increase of Ig A (p = 0.03). In the majority of autopsies (18/20), structural disorders of the testicular tissue, with signs of damage to germ cells were observed. DISCUSSION AND

conclusionCOVID-19 and its management strategies significantly affect male hormone levels and sperm quality at the onset of the disease. Postmortem examination of testicular tissue confirmed inflammation and viral infiltration of the testicles. However, in patients with moderate to severe disease, the studied parameters of the testicular function returned to normal values within 3 months.

Indexed as

COVID-19Follicle Stimulating HormoneHumansLuteinizing HormoneMalePandemicsProspective StudiesSARS-CoV-2SemenTestisTestosteroneFollicle Stimulating HormoneLuteinizing HormoneTestosteroneCOVID-19male fertilitySARS-CoV-2testes

Identifiers

PMID35124885
PMCPMC9111462
OpenAlexW4210492090

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.